Ethyl 2-(1-chloroethoxy)acetate | 34006-60-5

• 物质功能分类: 化学试剂 - 有机试剂 - 醚类
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Ethyl 2-(1-chloroethoxy)acetate
• CAS: 34006-60-5
• 化学式: C₆H₁₁ClO₃
• 分子量: 166.6
• InChiKey: WDCHMODANTVRTF-UHFFFAOYSA-N

物化性质

• 沸点：
  234.82°C (rough estimate)
• 密度：
  1.2277 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  10
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/38,S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2918990090
• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P261,P280,P301+P312,P302+P352,P305+P351+P338
• 危险品运输编号：
  1760
• 危险性描述：
  H302,H315,H318,H335

文献信息

• NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPAR-RECEPTORS
  申请人：Boiteau Jean-Guy

  公开号：US20090012129A1

  公开（公告）日：2009-01-08

  Novel biaromatic compounds that modulate peroxisome proliferator-activator receptors, known as PPAR, having the formula (I): are formulated into pharmaceutical compositions useful in human or veterinary medicine, or alternatively, in cosmetic compositions.

  将调节过氧化物酶增殖激活受体（PPAR）的新型双芳香化合物配方（I）制成药用组合物，可用于人类或兽医医学，或者用于化妆品组合物。
• [EN] NOVEL COMPOUNDS THAT MODULATE PPARgamma TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS<br/>[FR] NOUVEAUX COMPOSES QUI MODULENT LES RECEPTEURS DE TYPE PPAR DOLLAR G(G) ET UTILISATIONS DE CEUX-CI DANS DES COMPOSITIONS COSMETIQUES OU PHARMACEUTIQUES
  申请人：GALDERMA RES & DEV

  公开号：WO2004113331A1

  公开（公告）日：2004-12-29

  The invention relates to novel compounds corresponding to the general formula (I) below: (I) and also to the method for preparing them, and to their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism),-or alternatively in cosmetic compositions.

  该发明涉及与下列一般式（I）相对应的新化合物：（I），以及用于制备它们的方法，以及它们在用于人类或兽医药物组合物中的用途（在皮肤病学以及心血管疾病、免疫疾病和/或与脂质代谢有关的疾病领域），或者在化妆品组合物中的用途。
• CHROMOIONOPHORE AND METHOD OF DETERMINING CALCIUM IONS
  申请人：HE Huarui

  公开号：US20070259438A1

  公开（公告）日：2007-11-08

  The invention relates to methods of determining calcium ions in a sample, wherein the ions are contacted with a compound having chromophoric moiety and an ionophoric moiety, where the ionophoric moiety interacts with the calcium ions present in the sample, resulting in the chromophoric moiety changing its radiation absorption properties in the ultraviolet and visible regions of the spectrum. For example, a change in an intensity of an absorption maximum is measured and the ion concentration is determined accordingly.

  本发明涉及一种测定样品中钙离子的方法，其中将离子与具有色团和离子诱导基团的化合物接触，其中离子诱导基团与样品中存在的钙离子相互作用，导致色团在紫外和可见光谱区的辐射吸收特性发生变化。例如，测量吸收峰强度的变化，据此确定离子浓度。
• Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
  申请人：Clary Laurence

  公开号：US20060148862A1

  公开（公告）日：2006-07-06

  Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.

  具有以下一般式（I）的新化合物在人类或兽医学中具有广泛的应用（在皮肤病学中，以及在心血管疾病、免疫疾病和/或与脂质代谢有关的疾病领域），或者被制成化妆品组合物。
• METHODS OF MODULATING PPAR GAMMA-TYPE RECEPTORS
  申请人：CLARY Laurence

  公开号：US20100099689A1

  公开（公告）日：2010-04-22

  Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.

  具有以下一般式（I）的新化合物在人类或兽医学中具有广泛的应用（在皮肤科以及心血管疾病、免疫疾病和/或与脂质代谢相关的疾病领域），或者被制成化妆品组合物。